Eagle Pharmaceuticals Inc expected to post earnings of 83 cents a share - Earnings Preview

Eagle Pharmaceuticals

29/10/2021 15:05

* Eagle Pharmaceuticals Inc  EGRX.OQ   EGRX.O  is expected
to show a fall in quarterly revenue when it reports results on
November 1 (estimated). 
* The Woodcliff Lake, New Jersey-based company is expected to
report  a 7.1% decrease in revenue to $46.4 million from $49.93
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Eagle Pharmaceuticals
Inc is for earnings of 83 cents per share. For the same quarter
last year, the company reported earnings of $1.17 per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Eagle
Pharmaceuticals Inc is $48.5​, about 8.2% below​ its last
closing price of $52.49. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jun. 30 2021  0.75        0.80       0.93      Beat    16.3
 Mar. 31 2021  0.74        0.65       0.24      Missed  -63.1
 Dec. 31 2020  -0.20       -0.17      0.96      Beat    656.5​
 Sep. 30 2020  0.33        0.30       1.17      Beat    296.6
 Jun.          0.26​       0.24       0.57      Beat    142.6​
 30​ 2020​                                              
 Mar. 31 2020  0.58        0.57       0.84      Beat    48​
 Dec. 31 2019  0.50        0.47       0.48      Beat    3.2
 Sep. 30 2019  0.42        0.43       0.26      Missed  -39.2
 This summary was machine generated October 29 at 14:05 GMT.  All
figures in US dollars unless otherwise stated